Analyst consensus rating
LivaNova Analyst Rating: Buy
Direct answer
LivaNova's consensus rating is Buy.
10 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $89.10.
Forecast evidence checked September 27, 2026.
Get free LivaNova email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $76.63
- Average price target
- $89.10
- High price target
- $100.00
- Low price target
- $75.00
- Low target gap
- -2.1%
- Target upside
- +16.3%
- High target gap
- +30.5%
- Target range width
- 32.6%
- Consensus rating
- Buy
- Analysts
- 10
- Evidence date
- September 27, 2026
- Valid through
- October 4, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for LivaNova?
LivaNova has a verified Buy consensus. The same dataset has an average price target of $89.10.
How far are LivaNova's low and high targets from the recorded price?
The low target implies -2.1%, while the high target implies +30.5%.
How many analysts are included in LivaNova's consensus?
The verified consensus includes 10 analysts.
How is LivaNova's target upside or downside calculated?
The average target of $89.10 is divided by the recorded price of $76.63, then one is subtracted to produce +16.3%. This does not guarantee a future return.
When was LivaNova's analyst forecast verified?
The data was verified on 2026-09-27. The dataset is valid through 2026-10-04.